You have 9 free searches left this month | for more free features.

MiRNA-146a

Showing 1 - 25 of 5,620

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially

Completed
  • Potentially Malignant Lesions, Oral Lichen Planus, Leukoplakia
  • Real-time Polymerase Chain Reaction technique
  • Fayoum, Egypt
    Fayoum University
Feb 7, 2023

Interplay of miRNA-146a and miRNA-126 in Chronic Periodontitis

Completed
  • Chronic Periodontitis
  • +2 more
    • Chennai, Tamil Nadu, India
      Meenakshi Ammal Dental college
    Oct 9, 2020

    MicroRNAs and Cytokines in Peri-Implantitis Tissue

    Active, not recruiting
    • Peri-implantitis
      • Baghdad, Iraq
        Munir
      Mar 14, 2023

      MicroRNA-1 and MicroRNA-133a Levels After Acute Exercise in

      Recruiting
      • To Determine the Levels of miRNA1 and miRNA133a Before and After Exercise
      • miRNA levels analysis from saliva samples
      • Istanbul, Turkey
        Yeditepe University
      Oct 11, 2023

      Effects of Immunotherapy Trial in Zagazig (Sublingual immunotherapy)

      Completed
      • Effects of Immunotherapy
      • Sublingual immunotherapy
      • Zagazig, Egypt
        Fatma Zohry Kamel Khater
      Dec 18, 2022

      Osteoarthritis, Knee, Epigenetic Disorder, Quality of Life Trial in Istanbul (Exercise Programme, Experiments)

      Completed
      • Osteoarthritis, Knee
      • +4 more
      • Exercise Programme
      • Experiments
      • Istanbul, Turkey
        Bakırköy Dr. Sadi Konuk Training and Hospital Research Hospital,
      May 16, 2023

      Role of miRNAs in CVD and Periodontitis

      Completed
      • Cardiovascular Diseases
      • Periodontal Diseases
      • Observation of Evaluation of gingival crevicular fluid miRNA 7a-5p, miRNA 21-3p, miRNA 21-5p, miRNA 200b-3p, miRNA 200b-5p, miRNA 100-5p, miRNA 125-5p levels.
      • Catania, CT, Italy
        University of Catania
      May 16, 2022

      miRNA as a Growth Plate Marker After GH

      Recruiting
      • MicroRNAs: D13.444.735.790.552.500
        • São Paulo, SP, Brazil
          Santa Casa SP School of Medical Sciences
        Jul 7, 2023

        Myasthenia Gravis Trial in Guangzhou (Body fluid diagnosis)

        Enrolling by invitation
        • Myasthenia Gravis
        • Body fluid diagnosis
        • Guangzhou, Guangdong, China
          First Affiliated Hospital of Jinan University
        May 25, 2023

        COVID-19 Trial in Roma (miRNA analysis in plasma)

        Completed
        • COVID-19
        • miRNA analysis in plasma
        • Roma, Italy
          Mingrone Geltrude
        Feb 21, 2023

        Therapeutic Efficiency in Lung Squamous Carcinoma

        Recruiting
        • Lung Neoplasm
        • +2 more
        • collect plasma samples and clinical features
        • Tianjin, Tianjin, China
          TianjinCIH
        May 10, 2023

        miRNA in Sweat,Novel Digital Biomarker for Detection of Active

        Suspended
        • Active Tuberculosis
        • Next Generation Sequencing
        • Basel, Switzerland
          Chief Medical Information Office (CMIO), University Hospital Bas
        Aug 8, 2022

        Organ Protection Trial (Lidocaine, Normal saline)

        Not yet recruiting
        • Organ Protection
        • (no location specified)
        Aug 13, 2022

        Non Hodgkin Lymphoma and Acute Leukemia Trial in Sohag (real time pcr)

        Not yet recruiting
        • Non Hodgkin Lymphoma and Acute Leukemia
        • real time pcr
        • Sohag, Egypt
          Sohag University Hospital
        Jul 26, 2022

        Hypertonic Saline, Isotonic Saline Trial in Aalborg (hypertonic saline, Saline injection, Blood sampling)

        Active, not recruiting
        • Hypertonic Saline
        • Isotonic Saline
        • hypertonic saline
        • +2 more
        • Aalborg, Nordjylland, Denmark
        • +1 more
        Jan 26, 2022

        Including miRNA-based Tumor Signatures in Diffuse Large B Cell

        Not yet recruiting
        • Diffuse Large B Cell Lymphoma
        • Relapsed Non-Hodgkin Lymphoma
        • no intervention (observational study)
        • Napoli, Italy
        • +2 more
        Feb 17, 2023

        Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome Trial in Hershey (microRNA-146a level, microRNA-192 level,

        Recruiting
        • Neonatal Opioid Withdrawal Syndrome
        • Neonatal Abstinence Syndrome
        • microRNA-146a level
        • +2 more
        • Hershey, Pennsylvania
          Penn State Milton S. Hershey Medical Center
        Jun 30, 2023

        Antioxidative Stress, End Stage Renal Disease on Dialysis Trial in Cairo (Alpha lipoic acid, Selenium)

        Completed
        • Antioxidative Stress
        • End Stage Renal Disease on Dialysis
        • Cairo, Egypt
          Ain Shams University
        Mar 1, 2022

        Fragile X Syndrome (FXS) Trial in Stanford (18F-FTC-146)

        Withdrawn
        • Fragile X Syndrome (FXS)
        • Stanford, California
          Stanford University
        Nov 10, 2022

        microRNA in Erosive Hand Osteoarthritis and Psoriatic Arthritis

        Completed
        • Erosive Osteoarthritis
        • Psoriatic Arthritis
        • miRNA
        • Siena, Italy
          Rheumatology Unit Azienda Ospedaliera Universitaria Senese
        Jan 4, 2023

        Pool of miRNA to Improve Early Management of Perinatal Asphyxia

        Recruiting
        • Hypoxic-Ischemic Encephalopathy
        • Asphyxia Perinatal
        • Metabolic acidosis
        • +2 more
        • Naples, Italy
        • +1 more
        Aug 3, 2023

        Rheumatoid Arthritis Trial in Sakarya (exercise, gene expressions of miRNA)

        Completed
        • Rheumatoid Arthritis
        • exercise
        • gene expressions of miRNA
        • Sakarya, Turkey
          Sakarya Training and Research Hospital
        Jun 13, 2023

        Keratoconus Trial (Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146%)

        Not yet recruiting
        • Keratoconus
        • Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% with UV light
        • Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% without UV light
        • Boston, Massachusetts
          Massachusetts Eye and Ear Infirmary
        Jan 12, 2023

        Differentiate Statuses of Periodontitis

        Active, not recruiting
        • Periodontitis
          • Baghdad, Iraq
            University of Baghdad
          Feb 1, 2023

          Solid Tumor, Lymphoma Trial in Beijing (HG146, PD-(L)1 antibody)

          Recruiting
          • Solid Tumor
          • Lymphoma
          • Beijing, China
            National Cancer Center/Cancer Hospital
          Mar 16, 2022